shot-button
Ganesh Chaturthi Ganesh Chaturthi
Home > News > India News > Article > Jayalalithaa death AIIMS panel gives clean chit to Apollo Hospital says correct medical procedures followed

Jayalalithaa death: AIIMS panel gives clean chit to Apollo Hospital, says 'correct' medical procedures followed

Updated on: 21 August,2022 03:16 PM IST  |  New Delhi
ANI |

With direction from the Supreme Court, the AIIMS panel was formed to assist Arumughaswamy Commission

Jayalalithaa death: AIIMS panel gives clean chit to Apollo Hospital, says 'correct' medical procedures followed

File Photo

A report by the All India Institute of Medical Sciences' panel of doctors has asserted that the treatment provided to late Tamil Nadu Chief Minister Jayalalithaa was as per "correct medical practice and no errors" have been found in the care provided. This clean chit provided relief for Apollo Hospital where Jayalalithaa was admitted.


With direction from the Supreme Court, the AIIMS panel was formed to assist Arumughaswamy Commission.


The panel found all the final diagnosis and timeline of events of Jayalalithaa's health was fully observed and also agreed with Apollo's treatment and diagnosis.


After the demise of Jayalalithaa in December 2016, full-scale politics erupted over the cause of her death and the medical procedures followed during her hospitalisation.

Also Read: Netaji died in air crash, tales of non-existent afterlife are attempts to exploit his popularity: Sugata Bose

Former Tamil Nadu chief minister O. Pannerselvam had requested a probe over her death which led to the formation of the Arumughaswamy Commission.

Arumughaswamy Commission commenced its investigation in November 2017 with many hearings of close aides of Jayalalithaa and doctors who provided treatment, then Tamil Nadu Health Minister Vijayabhakar, then Health Secretary Radhakrishnan, then Finance Minister of Tamil Nadu and AIADMK senior leader O. Pannerselvam.

Over 157 witnesses in relation to Jayalalithaa have appeared before Arumughaswamy Commission and have put forward their points of view.

Meanwhile, in 2019, Apollo Hospital moved to Madras High Court seeking an interim stay on proceedings of the probe panel relating to the medical treatment given to former Jayalalitha.

The plea claimed that the probe panel has gone beyond the scope of its terms and references and behaved in a partial manner to fasten liability on Apollo Hospitals. Whereas Madras High Court rejected Apollo Hospital's plea to objections to the enquiry commission.

Following this Apollo appealed to Supreme Court against the Madras High Court order where the apex court ordered AIIMS to set up a medical board to assist Arumughaswamy Commission to understand the medical treatment provided to Jayalalithaa.

Based on the medical records, a final diagnosis was made of Bacteremia and Septic shock with a respiratory infection.

There was also evidence of heart failure. She had uncontrolled diabetes at admission which was treated. There was also a history of hypertension, hyperthyroid, asthmatic, irritable bowel syndrome and atopic dermatitis and the medical panel at AIIMS has said that it "agrees with the final diagnosis".

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever.

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!

Register for FREE
to continue reading !

This is not a paywall.
However, your registration helps us understand your preferences better and enables us to provide insightful and credible journalism for all our readers.

Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK